Kyriazi Theo Melas's Net Worth
$102 Million
Who is Kyriazi Theo Melas?
Kyriazi Theo Melas has an estimated net worth of $102 Million. This is based on reported shares across multiple companies, which include GlenRose Instruments Inc., Kaleido Biosciences, Inc., Valeant Pharmaceuticals International, Inc., THERMO ELECTRON CORP, Cyberkinetics Neurotechnology Systems, Inc., Codiak BioSciences, Inc., Evelo Biosciences, Inc., VALEANT PHARMACEUTICALS INTERNATIONAL, and HELICOS BIOSCIENCES CORP.
SEC CIK
Kyriazi Theo Melas's CIK is 0001216078
Past Insider Trading and Trends
2009 was Kyriazi Theo Melas's most active year for acquiring shares with 14 total transactions. Kyriazi Theo Melas's most active month to acquire stocks was the month of May. 2004 was Kyriazi Theo Melas's most active year for disposing of shares, totalling 23 transactions. Kyriazi Theo Melas's most active month to dispose stocks was the month of May. 2004 saw Kyriazi Theo Melas paying a total of $3,950,083.29 for 271,540 shares, this is the most they've acquired in one year. In 2004 Kyriazi Theo Melas cashed out on 456,876 shares for a total of $5,604,669.87, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GlenRose Instruments Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
∞
| 33.33K |
$7.50 | $249,997.50 | 33.33K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.43% | 950 |
—
|
—
| 223.09K |
May 2
| |||
Form 4
| +0.11% | 245 |
—
|
—
| 222.14K |
Dec 31
| |||
Form 4
| +0.06% | 140 |
—
|
—
| 221.89K |
Sep 30
| |||
Form 4
| +0.05% | 106 |
—
|
—
| 221.75K |
Jun 30
| |||
Form 4
| +0.73% | 1.61K |
—
|
—
| 221.65K |
May 22
| |||
Form 4
| +0.06% | 132 |
—
|
—
| 220.04K |
Mar 31
| |||
Form 4
| +0.09% | 192 |
—
|
—
| 219.91K |
Dec 31
| |||
Form 4
| +0.10% | 209 |
—
|
—
| 219.72K |
Sep 30
| |||
Form 4
| +0.10% | 228 |
—
|
—
| 219.51K |
Jun 30
| |||
Form 4
| +1.32% | 2.87K |
—
|
—
| 219.28K |
May 23
| |||
Form 4
| +0.10% | 224 |
—
|
—
| 216.41K |
Mar 31
| |||
Form 4/A
| +0.12% | 250 |
—
|
—
| 216.19K |
Dec 31
| |||
Form 4
| +0.16% | 250 |
—
|
—
| 157.21K |
Dec 31
| |||
Form 4
| +0.13% | 281 |
—
|
—
| 215.94K |
Sep 30
| |||
Form 4
| +0.15% | 316 |
—
|
—
| 215.66K |
Jun 30
| |||
Form 4
| -0.43% | -924.00 |
$88.21 | -$81,506.04 | 215.34K |
Jun 4
| |||
Form 4
| -2.45% | -5.44K |
$90.81 | -$614,057.22 | 216.26K |
May 30
| |||
Form 4
| +2.32% | 5.02K |
—
|
—
| 221.71K |
May 24
| |||
Form 4
| +0.16% | 341 |
—
|
—
| 216.69K |
Mar 31
| |||
Form 4/A
| +0.20% | 428 |
—
|
—
| 216.34K |
Dec 31
| |||
Form 4/A
| +0.20% | 428 |
—
|
—
| 216.34K |
Dec 31
| |||
Form 4
| +0.20% | 428 |
—
|
—
| 216.38K |
Dec 31
| |||
Form 4
| +0.21% | 463 |
—
|
—
| 215.92K |
Sep 30
| |||
Form 4
| +0.28% | 596 |
—
|
—
| 215.45K |
Jun 30
| |||
Form 4
| +3.90% | 8.06K |
—
|
—
| 214.86K |
Jun 4
| |||
Form 4
| +0.24% | 500 |
—
|
—
| 206.79K |
Mar 31
| |||
Form 4
| +2.21% | 4.4K |
—
|
—
| 203.79K |
May 19
| |||
Form 4/A
| +2.99% | 5.87K |
—
|
—
| 201.9K |
Dec 22
| |||
Form 4/A
|
∞
| 196.03K |
—
|
—
| 196.03K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
∞
| 166.02K |
—
|
—
| 166.02K |
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
THERMO ELECTRON CORP (TMO) Snapshot price: $611.33
VP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.69% | 27.12K |
$16.83 | -$355,782.90 | 158.2K |
Sep 16
| |||
Form 4
| -11.75% | -17.46K |
$29.14 | -$508,715.75 | 131.08K |
Jun 18
| |||
Form 4
| +71.32% | 61.84K |
$23.13 | -$891,322.89 | 148.54K |
Jun 10 - Jun 15
| |||
Form 4
| +1.27% | 1.07K |
$19.67 | -$18,754.96 | 85.46K |
Feb 11
| |||
Form 4
| -3.59% | -3.14K |
—
|
—
| 84.39K |
Nov 25
| |||
Form 4
| +5.92% | 4.89K |
$17.34 | -$863,875.24 | 87.53K |
Jul 25
| |||
No matching records found |
Cyberkinetics Neurotechnology Systems, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |